2013•Pharmacology Biochemistry and BehaviorOpen access

Glial cell-line derived neurotrophic factor (GDNF) replacement attenuates motor impairments and nigrostriatal dopamine deficits in 12-month-old mice with a partial deletion of GDNF

O. Meagan Littrell, Ann‐Charlotte Granholm, Greg A. Gerhardt, Heather A. Boger

Open full text 20 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 20 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Glial cell line-derived neurotrophic factor, Neurotrophic factors, Endocrinology, Internal medicine, Dopamine, Substantia nigra, Parkinson's disease, Tyrosine hydroxylase

Back to paper search Browse research topics Original source

Glial cell-line derived neurotrophic factor (GDNF) replacement attenuates motor impairments and nigrostriatal dopamine deficits in 12-month-old mice with a partial deletion of GDNF — Research Paper | ScholarLens